ARCHIVES

Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules

This article is from The Cancer Letter archive.

Vol. 25 No. 30 | July 30, 1999

Download PDF Visit The Full Archive

Related Articles

Immune System Booster Shown Safe For Prostate Cancer; Fewer Side Effects

August 29, 2008

President’s Cancer Panel Special Commission On Breast Cancer Named

April 25, 1992

NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.

December 1, 2000

FDA News: Agency Accepting Nominations For Patient Representatives

May 8, 1998

NIH Plans Conference On DCIS Diagnosis, Management

July 17, 2009

The Education Of Dan Flood Gets $60 Million Increase For NCI; House Votes HEW Money Bill

July 5, 1974